A phase 2, randomized, placebo-controlled clinical study on Lymfactin

Trial Profile

A phase 2, randomized, placebo-controlled clinical study on Lymfactin

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs AdVEGF-Herantis (Primary)
  • Indications Lymphoedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2017 New trial record
    • 22 Jun 2017 According to an Herantis Pharma media release, the company aims to submit an application to regulatory authorities by the end of 2017 for a phase II study. The company has initiated discussions on a Phase 2 study with regulatory authorities and study centers.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top